Home > Financial Ratios > NEULAND LABORATORIES

NEULAND LABORATORIES
EBIT Growth

    Back to All Ratios
NEULAND LABORATORIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for NEULAND LABORATORIES
Please provide your vote to see the results

NEULAND LABORATORIES Last 5 Year EBIT Growth History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   EBIT Growth(%) 44.64-14.6481.56139.20-22.38

What is the latest EBIT Growth ratio of NEULAND LABORATORIES ?

The latest EBIT Growth ratio of NEULAND LABORATORIES is 44.64 based on Mar2026 Consolidated results.
Year EBIT Growth
Mar202644.64
Mar2025-14.64
Mar202481.56
Mar2023139.20
Mar2022-22.38

How is EBIT Growth of NEULAND LABORATORIES Trending?

Years EBIT Growth % Change
Mar2026 44.64
Positive
Mar2025 -14.64
Negative
Mar2024 81.56
-41.41
Mar2023 139.2
Positive
Mar2022 -22.38 -

Other Financial Ratios of NEULAND LABORATORIES


Compare EBIT Growth ratio of peers of NEULAND LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NEULAND LABORATORIES ₹29,728.5 Cr 1.3% 20.9% 69.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹460,696.0 Cr 0.5% -4% 15.7% Stock Analytics
DIVIS LABORATORIES ₹246,063.0 Cr 9.1% 18.2% 47.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹191,515.0 Cr 3.6% 3.4% 36.4% Stock Analytics
CIPLA ₹114,554.0 Cr -1.2% -3.3% -10.8% Stock Analytics
DR REDDYS LABORATORIES ₹98,308.6 Cr -1.4% 2.9% -8% Stock Analytics


NEULAND LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NEULAND LABORATORIES

1.3%

20.9%

69.4%

SENSEX

-0.4%

-0.5%

-5.8%


You may also like the below Video Courses